
Hemant Sreenivasa Murthy MD
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Associate Professor of Medicine- Division of Hematologic Malignancies and Bone Marrow Transplant https://www.mayoclinic.org/biographies/murthy-hemant-s-m-d/bio-20464551
Join to View Full Profile
4500 San Pablo Road SJacksonville, FL 32224
Dr. Murthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hemant Murthy is a hematologist in Jacksonville, FL and is affiliated with Mayo Clinic Hospital in Florida and Associate Professor of medicine at the Mayo Clinic. He specializes in hematologic oncology and is experienced in immunotherapy, hematopoietic stem cell transplantation, car-T and immunotherapy, and leukemia and myeloid disorders
Education & Training
H. Lee Moffitt Cancer Center and Research InstituteBone marrow transplant , 2015 - 2016
Vidant Medical Center/East Carolina UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
Virginia Commonwealth University Health SystemFellowship, Hospice and Palliative Medicine, 2011 - 2012
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2008 - 2011
St. George's University School of MedicineClass of 2008
State University of New York at BinghamtonBS, Chemistry, 1998 - 2002
Certifications & Licensure
FL State Medical License 2015 - 2027
NC State Medical License 2012 - 2016
VA State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Resident/ Fellow Scholarship VCU Deparment of Medicine, 2012
- AAHPM HPNA Annual Assembly Palliative Medicine Access Fund Scholarship 2012
Clinical Trials
- Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) Start of enrollment: 2017 Aug 18
Publications & Presentations
PubMed
- Outcomes of Post-Transplant Rh-GCSF and Decitabine Maintenance Therapy in Patients With High-Risk Myeloid Neoplasm.Mathias Palmer, Anmol Baranwal, Rami Basmaci, Khalil Hassan, Jade Kutzke
American Journal of Hematology. 2025-10-01 - Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis.Kalyan V Nadiminti, Kwang W Ahn, Jinalben Patel, Qinghua Lian, Evandro Bezerra
Transplantation and Cellular Therapy. 2025-08-05 - Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR Analysis.Hemalatha G Rangarajan, Prakash Satwani, Megan M Herr, Min Chen, Michael J Martens
Blood Advances. 2025-07-30
Journal Articles
- Pharmacokinetic and Clinical Outcomes When Ideal Body Weight Is Used to Dose Busulfan in Obese Hematopoietic Stem Cell Transplant RecipientsJack W Hsu, Hemant S Murthy, Nature
Abstracts/Posters
- Diet Quality of Long-Term Allogeneic and Autologous Stem Cell Transplant (HCT) SurvivorsHemant S. Murthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Efficacy of Allogeneic Hematopoietic Cell Transplantation (HCT) in Sickle Cell Disease: Results of a Systematic Review/Meta-AnalysisHemant S. Murthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)Hemant S. Murthy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- The Perils Of Palliative Care- Recognizing When Palliative Interventions Are The Cause Of Symptom Burden.Annual Assembly of the American Academy of Hospice and Palliative Medicine and Hospice
- Lymphedema- A Growing Problem.Department of Hematology, Oncology and Palliative Medicine, Virginia Commonwealth University
Authored Content
- Recent Research Brings Improved Outcomes in Allogeneic Hematopoietic Cell TransplantationFebruary 2021
- State of the science: High-priority transplant trials for nonmalignant diseaseApril 2015
Press Mentions
Looking Back on 2020: A Successful Year of Research at Mayo Clinic in FloridaJanuary 5th, 2021
FDA Says CAR-T Therapy for Cancer Treatment May Increase Cancer RiskJanuary 24th, 2024
FDA Says Cancer Treatment CAR-T Therapy May Increase Risk of CancerJanuary 24th, 2024- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Fellow
- American Association of Hospice and Palliative MedicineMember
- American Society of NeurooncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








